KRAS G12C inhibitor 13 Catalog No.:M24067-C Oral administration of an equimolar

Oral administration of an equimolar dose of ATB-337 produced > 90% less small intestinal damage and showed no significant effect on the hematocrit

29)30)36-8-11(7-32-36)10-2-3-13(22)12(6-10)16(37)33-18(9-31)4-5-18/h2-3

5-dihydro-1H-pyrrol-3-yl)methyl]piperidin-4-one

Smiles: COC1=CC2[C@H]3CC[C@]4(C)C=CC[C@H]4[C@@H]3CCC=2C=C1C(N)=O

KRAS G12C inhibitor 13 Catalog No.:M24067-C Oral administration of an equimolarKRAS G12C inhibitor 13 is a KRAS G12C inhibitor extracted from patent WO2018143315A1, compound 30. Product information CAS Number: 2241719 75 3 Molecular Weight: 745. 83 Formula: C40H46F3N7O4 Chemical Name: 1 {7 [6 ethenyl 7 (5 methyl 1H indazol 4 yl) 2 {[1 (oxan 4 yl)piperidin 4 yl]oxy} 8 (2,2,2 trifluoroethoxy)quinazolin 4 yl] 2,7 diazaspiro[3. 5]nonan 2 yl}prop 2 en 1 one Smiles: